HomeDrug recalls
Medium severity

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

SourceFDA Drug Enforcement
CategoryDrug
SeverityMedium
Statusongoing
Recall dateDecember 12, 2025
ReportedDecember 31, 2025
Recalling firmMerck Sharp & Dohme LLC
Country / regionUnited States NC

Hazard

Presence of particulate matter: potential presence of metal particulates in the product.

Affected products

Related recalls

Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASI · May 20, 2026Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo US · May 20, 2026Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: · May 20, 2026Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Lab · May 13, 2026DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialys · May 13, 2026